Atrial fibrillation

Findings from a real-world data analysis of the U.S. Medicare database comparing the risk of stroke or systemic embolism and...


Amid growing uncertainty about the safety of Digoxin, a commonly used heart drug, a study led by Duke Clinical Research...


Stroke is a rare but serious complication of acute coronary syndrome. At present, no specific score exists to identify patients...


In addition to Warfarin ( Coumadin ), there are four non-vitamin K antagonist oral anticoagulants ( NOACs ) available for...


Researchers performed a prospective, randomized clinical study ( PRESAGE ) to assess whether prophylactic treatment with Metoprolol or Losartan, initiated...


While bleeding is a well-known complication of Warfarin ( Coumadin ) use and is thought to be a contributory cause...


Various ablation strategies of persistent atrial fibrillation ( PersAF ) have had disappointing outcomes, despite concerted clinical and research efforts,...


The optimal rhythm management strategy for people with non-paroxysmal ( persistent or long-standing persistent ) atrial fibrilation is currently not...


Available pharmacological options for rhythm control strategy in atrial fibrillation are limited by sub-optimal efficacy and potentially serious adverse events....


Randomized controlled trials ( RCTs ) regarding use of Ranolazine for the prevention and cardioversion of atrial fibrillation have yielded...


Although there are many different antiarrhythmic drugs approved for rhythm management of atrial fibrillation, little comparative effectiveness data exist to...


A study has evaluated the prospective association between circulating 25-hydroxyvitamin D [ 25(OH)D ] and atrial fibrillation risk. 12 303 participants...


Death in dialysis patients results mainly from cardiovascular and cerebrovascular diseases. No prospective study has compared the rates of mortality...


Researchers at University of Manchester ( Manchester, UK = previously reported Omega-3 polyunsaturated fatty acids ( n-3PUFAs ) supplementation does...


Contrary to current clinical belief, regular Caffeine consumption does not lead to extra heartbeats, which, while common, can lead in...


The FDA ( Food and Drug Administration ) has approved Imbruvica ( Ibrutinib ) as a first-line treatment for patients...


The FDA ( Food and Drug Administration ) has approved the first pacemaker that does not require the use of...


A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that atrial fibrillation...


Among nearly 35,000 initially healthy women who were followed-up for about 20 years, those with new-onset atrial fibrillation had an...


Apixaban ( Eliquis ), a direct factor Xa inhibitor approved for thromboembolic prophylaxis in patients with non-valvular atrial fibrillation, is...